Abstract
Objective: To evaluate the use of aerosolized magnesium sulfate (MgSO4) in combination with inhaled betaagonists compared to inhaled beta-agonists alone in the treatment of acute asthma. Methods: Published (1966-2005) randomized controlled trials were retrieved using different databases, bibliographic reviews of primary research, review articles, and citations from texts. The primary outcome measure was pulmonary function. Results: Five out of 16 potentially eligible studies met criteria for inclusion in the meta-analysis. They included 187 adults and 62 children who were treated in an emergency department. Patients that received MgSO4 showed non-significant improvement in pulmonary function (SMD = -0.21, 95%CI:-0.52 to 0.10, p = 0.18). The advantage of the use of MgSO4 was demonstrated only in patients with life-threatening acute asthma (baseline FEV1 or PEF < 30% predicted) (SMD = - 1.10; 95%CI: -1.80 to -0.39, p = 0.002; I2 = 0%). Nebulized MgSO4 with beta-agonists showed a marginal significant reduction in admission rate compared to beta-agonists alone (RR = 0.63, 95% CI: 0.39 to 1.01, p = 0.06, I2 = 0%). Conclusions: Data suggests that MgSO4 presents a beneficial effect in terms of pulmonary function only in the subgroup of life-threatening acute asthma patients. However, the small number of studies selected, the standard treatment used in all trials, and the beta-agonist delivery method restricts this conclusion.
Keywords: Magnesium sulphate, beta-agonists, acute severe asthma, emergency department treatment
Current Drug Therapy
Title: Is There a Place for Nebulized Magnesium Sulfate in the Treatment of Acute Asthma? A Systematic Review
Volume: 1 Issue: 2
Author(s): Gustavo J. Rodrigo and Luis J. Nannini
Affiliation:
Keywords: Magnesium sulphate, beta-agonists, acute severe asthma, emergency department treatment
Abstract: Objective: To evaluate the use of aerosolized magnesium sulfate (MgSO4) in combination with inhaled betaagonists compared to inhaled beta-agonists alone in the treatment of acute asthma. Methods: Published (1966-2005) randomized controlled trials were retrieved using different databases, bibliographic reviews of primary research, review articles, and citations from texts. The primary outcome measure was pulmonary function. Results: Five out of 16 potentially eligible studies met criteria for inclusion in the meta-analysis. They included 187 adults and 62 children who were treated in an emergency department. Patients that received MgSO4 showed non-significant improvement in pulmonary function (SMD = -0.21, 95%CI:-0.52 to 0.10, p = 0.18). The advantage of the use of MgSO4 was demonstrated only in patients with life-threatening acute asthma (baseline FEV1 or PEF < 30% predicted) (SMD = - 1.10; 95%CI: -1.80 to -0.39, p = 0.002; I2 = 0%). Nebulized MgSO4 with beta-agonists showed a marginal significant reduction in admission rate compared to beta-agonists alone (RR = 0.63, 95% CI: 0.39 to 1.01, p = 0.06, I2 = 0%). Conclusions: Data suggests that MgSO4 presents a beneficial effect in terms of pulmonary function only in the subgroup of life-threatening acute asthma patients. However, the small number of studies selected, the standard treatment used in all trials, and the beta-agonist delivery method restricts this conclusion.
Export Options
About this article
Cite this article as:
Rodrigo J. Gustavo and Nannini J. Luis, Is There a Place for Nebulized Magnesium Sulfate in the Treatment of Acute Asthma? A Systematic Review, Current Drug Therapy 2006; 1 (2) . https://dx.doi.org/10.2174/157488506776931003
DOI https://dx.doi.org/10.2174/157488506776931003 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
Current Molecular Medicine Relevance of Bioassay of Biologically Active Substances (BAS) with Geroprotective Properties in the Model of the Nematode <i>Caenorhabditis Elegans</i> in <i>In Vivo</i> Experiments
Current Aging Science Patent Selections :
Recent Patents on Cardiovascular Drug Discovery Vitamin D Intake and Obesity in Occupational Asthma Patients and the Need for Supplementation
Endocrine, Metabolic & Immune Disorders - Drug Targets Descriptive Analysis of Mortality Predictors in H1n1 Influenza in South Indian Patients
Infectious Disorders - Drug Targets Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies
Current Medicinal Chemistry Severe Preeclampsia
Current Women`s Health Reviews Recent Developments in the Synthesis of Bicyclic Condensed Pyrimidinones
Current Organic Chemistry A Sensitive Determination of Ammonia and Nitrite in Exhaled Breath Condensate of Healthy Humans by Using Berthelot Reaction
Current Pharmaceutical Analysis Characterization of the Immune Inflammatory Profile in Obese Asthmatic Children
Endocrine, Metabolic & Immune Disorders - Drug Targets Antioxidants in the Practice of Medicine; What Should the Clinician Know?
Cardiovascular & Hematological Disorders-Drug Targets Pharmacological Intervention of Cyclooxygenase-2 and 5-Lipoxygenase Pathways. Impact on Inflammation and Cancer
Current Pharmaceutical Design Blood Coagulation as an Intrinsic Pathway for Proinflammation: A Mini Review
Inflammation & Allergy - Drug Targets (Discontinued) Involvement of Orbital Structures in Rheumatic Disease
Current Rheumatology Reviews Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) COVID-19: Challenges and its Technological Solutions using IoT
Current Medical Imaging Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Rho Kinase (ROCK) Inhibitors and Their Application to Inflammatory Disorders
Current Topics in Medicinal Chemistry Drug Repositioning: A Unique Approach to Refurbish Drug Discovery
Current Drug Discovery Technologies Cross-Reactive Reactions to Nonsteroidal Anti-Inflammatory Drugs
Current Pharmaceutical Design